Baby and kids' product recalls
6719 federal recalls on file. Every federal recall touching baby and kids' products — toys, formula, baby food, cribs, strollers, child seats. Sourced from CPSC, FDA, USDA, and NHTSA, translated into plain English.
- 2020-09-09FDA-FoodGiant EagleClass ISpinach Salad Ranch Dressing PLU#21738800000 Expiration date 8/5/2020. Ingredients:SALAD [RANCH DRESSING (SOYBEAN OIL, CULTURED BUTTERMILK, WATER, MALTODEXTRIN, DISTILLED VINEGAR, EGG YOLK, CONTAINS LESS THAN 2% OF SALT, SUGAR, DRIED GARLIC, BUTTERMILK SOLIDS, LACTIC ACID, SPICE, XANTHAN GUM, DRIED ONION, CORN STARCH, MUSTARD SEED, GUAR GUM, AUTOLYZED YEAST EXTRACT, NATURAL FLAVOR), BABY SPINACH, GRAPE TOMATOES, EGG, CHEDDAR CHEESE (PASTEURIZED MILK, CHEESE CULTURE, SALT, ENZYMES AND ANNATTO (CO
Potential contamination with Salmonella Newport in onions and prepared foods containing onions.
- 2020-09-09FDA-FoodGiant EagleClass IMD Berry Feta Salad PLU# 20660900000. Expiration date 8/4/2020. Ingredients:SALAD [STRAWBERRIES, BABY SPINACH, FETA CHEESE ((PASTEURIZED PART-SKIM MILK, CHEESE CULTURE, SALT, ENZYMES), POWDERED CELLULOSE TO PREVENT CAKING), BALSAMIC VINAIGRETTE (SEE DRESSING CUP), CANDIED PECANS (PECANS, SUGAR, HONEY, CANOLA AND/OR PEANUT OIL, SALT), BLACKBERRIES, SPRING MIX (GREEN LEAVES [FRISEE, WILD ARUGULA, MACHE], RED LEAVES [RADICCHIO], MAY CONTAIN THE FOLLOWING: GREEN LEAVES [ROMAINE HEARTS, TANGO, MIZUNA
Potential contamination with Salmonella Newport in onions and prepared foods containing onions.
- 2020-08-27CPSCMystic Moments UK, of United KingdomAmazon Recalls Mystic Moments Birch Sweet Essential Oil Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The product contains the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- 2020-08-27CPSCCalmer Solutions, of United KingdomAmazon Recalls Calmer Solutions Wintergreen Essential Oil Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The product contains the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- 2020-08-26CPSCCommunicorp Inc., of Columbus, Ga.Communicorp Recalls Plush Aflac Doctor Duck Due to Violation of Federal Lead Content Ban; Lead Poisoning Hazard
The buttons on the lab coat worn by the Doctor Duck contain levels of lead that exceed the federal lead content standard. Lead is toxic if ingested by young children and can cause adverse health issues.
- 2020-08-21CPSCAurorasports Ltd., of Chinawoom bikes USA Recalls Children's Helmets Due to Risk of Head Injury (Recall Alert)
The recalled helmets do not meet the federal safety standard, posing a risk of head injury.
- 2020-08-19FDA-DeviceBioseal CorporationClass IIBioseal Trachea Extender 1/pl 50pk/Cs, REF TRAX01/50, LOT XXXX, STERILE EO, Single Use Only, Date of Manufacture XXXX, Expiration Date XXXX, LF, UDI: (01) 00630094916019 - Product Usage: Airway connectors intended to connect a breathing gas source to a tracheal tube, tracheostomy tube, or mask.
The reported stress crack in the port of the swivel elbow where the flip cap is inserted could result in leakage from the breathing system resulting in the prescribed ventilation not being delivered to the patient. These cracks could possibly leak if they reach a significant size and pose a serious heath risk to patient.
- 2020-08-19FDA-DeviceIon Beam Applications S.A.Class IIProteus 235 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.
Signature from the user is necessary to proceed with specific actions in the Proton Therapy System (PTS). IBA became aware that the PTS does not accept user names with more than ten characters. It is an issue when the user has no other choice than resuming an aborted treatment field based on the overall delivered dose displayed on the Dose Counter Electronic Unit (DCEU). User s signature is required to perform this action. If the signature contains more than ten characters, the user will not be able to complete the aborted treatment field. An additional issue applies to Electronic Medical Record (EMR) centric sites and may increase the probability of not being able to complete an aborted treatment field. It is not possible, in a new session, to resume from a local partial archive if the Patient Positioning System (PPS) position has changed. If the user captures the PPS position at every session in the Oncology Information System (OIS) just after the setup process, the prescribed PPS position is changed for the next session in the OIS. This includes the partial continuation session. Therefore, when comparing the prescribed PPS position between OIS and local database, the PTS sees a difference and rejects the local partial archive. This problem forces the user to resume the interrupted irradiation based on the overall delivered dose displayed on the DCEU instead of resuming from the full details of the interrupted beam.
- 2020-08-19FDA-FoodUpspring,ltdClass IUpSpring Baby Iron + Immunity MULTI + IRON + ZINC Promotes nutrition For Healthy Growth + Immune System Support For Infants 4 months + Natural Grape Flavor Easy To Use Dropper Dietary Supplement NET WT 2 FL OZ (60 ML)UPC No: 859188006805 packaged in dark brown glass bottles and placed in paper carton with dropper supplier in carton
May contain undeclared milk
- 2020-08-19FDA-DrugEosera, Inc.Class IIEar Pain MD Pain Relief Drops For Kids (lidocaine HCl Monohydrate 4%) 0.5 FL OZ (15 mL) bottles, Eosera, Inc. 5000 South Freeway Fort Worth, TX 76115, NDC 72429-0070-8
cGMP Deviations.
- 2020-08-19CPSCHasbro, Inc., of Pawtucket, R.I.Hasbro Recalls Super Soaker XP 20 and XP 30 Water Blasters Due to Violation of Federal Lead Content Ban; Sold Exclusively at Target
The decorative sticker on the water tank of the water blaster toys contain levels of lead in the ink that exceed the federal lead content ban. Lead is toxic if ingested by young children and can cause adverse health effects.
- 2020-08-12CPSCThule Group, of SwedenThule Recalls Strollers Due to Injury Hazard
The stroller's handlebar can detach, posing an injury hazard to children.
- 2020-08-12CPSCCrown Darts UK, of United KingdomCPSC and Crown Darts UK Warn Consumers to Stop Using and Dispose of Banned Lawn Dart Sets; Recalling Firm is Unable to Conduct Recall
Lawn darts are banned in the U.S. due to serious risks of skull punctures and other serious injuries, particularly to children.
- 2020-08-11CPSCMoveis K1 LTDA, of BrazilTransform Recalls Four-Drawer Chests Due to Tip-Over and Entrapment Hazards; Sold Exclusively at Kmart
The recalled chests are unstable and can tip over if not anchored to the wall, posing serious tip-over and entrapment hazards that can result in death or injuries to children.
- 2020-08-06CPSCREVIVE Essential Oils LLC, of San Francisco, Calif.REVIVE Essential Oil Recalls Wintergreen and Birch Essential Oils and Sore No More, Ache Away and Breeze Essential Oil Blends Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The products contain the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- 2020-08-05USDAPublic Health AlertDo not eat Taylor Farms or Amana meat products
Product Contamination
- 2020-08-05FDA-DrugMasterPharm LLCClass IIFormula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone acetonide 0.01%), a) 0.5 FL OZ (15 mL), b) 2 FL OZ (60 mL) bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Lack of Processing Controls (lack of assurance of conformity to specifications).
- 2020-08-05FDA-DrugMasterPharm LLCClass IIFormula 82F (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone Acetonide 0.01%/Finasteride 0.25%), 0.5 FL OZ (15 mL) bottle MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600.
Lack of Processing Controls (lack of assurance of conformity to specifications).
- 2020-07-30CPSCBio Source Naturals, of New Boston, Mich.Bio Source Naturals Recalls Wintergreen and Birch Sweet Essential Oils Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The products contain the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products are not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- 2020-07-29FDA-DrugTransliquid Technologies, LLCClass IMystic Shield PROTECTION, ALCOHOL ANTISEPTIC 70%, Topical Solution, Antiseptic Hand Rub, Non-sterile Solution, Extra strength Formula*, 8.45 fl. oz. (250 ml) bottle, Labeled with green or blue labels, Manufactured by Mystic Intl S.A. de C.V. UPC barcode: 7 87790 33952 6
Chemical Contamination: Presence of Undeclared Methanol
- 2020-07-23CPSCBulk Apothecary, of Aurora, OhioBulk Apothecary Recalls Nature's Oil Wintergreen and Birch Essential Oils Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The products contain the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products are not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATIONEX 5CC, INJECT FORMULA. Product Number: 390-0005, UDI: 813845020023 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATIONEX 2CC INJECT FORMULA. Product Number: 390-0002, UDI: 813845020009 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION, 5CC, INJECT FORMULA. Product Number: 390-2005, UDI: 813845020054 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION, 5CC, IMPACT FORMULA. Product Number: 390-2105, UDI: 813845020085 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION, 3CC, IMPACT FORMULA. Product Number: 390-2103, UDI: 813845020078 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION, 10CC, INJECT FORMULA. Product Number: 390-2010, UDI: 813845020061 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resorbs
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION IMPACT 10CC and OSTEOVATION, 10CC, IMPACT FORMULA, Product Number: 390-2110, UDI: 813845020092 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a b
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION EX, 5CC, IMPACT FORMULA. Product Number: 390-0205, UDI: 813845020047 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resor
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
- 2020-07-22FDA-DeviceSkeletal Kinetics, LlcClass IIOSTEOVATION EX, 3CC, IMPACT FORMULA. Product Number: 390-0203, UDI: 813845020030 - Product Usage: Callos is indicated to fill bony voids or gaps of the skeletal system (i.e. extremities, spine, pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Callos Bone Void Filler is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. The product provides a bone void filler that resor
Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.
Get notified about new baby recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief